关注
Dr Saba Khan
Dr Saba Khan
Jamia Hamadard
在 jamiahamdard.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride
B Gaba, M Fazil, S Khan, A Ali, S Baboota, J Ali
Bulletin of Faculty of Pharmacy, Cairo University 53 (2), 147-159, 2015
2262015
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
S Khan, S Baboota, J Ali, S Khan, RS Narang, JK Narang
International journal of pharmaceutical investigation 5 (4), 182, 2015
1932015
Nanocarriers as treatment modalities for hypertension
T Alam, S Khan, B Gaba, MF Haider, S Baboota, J Ali
Drug delivery 24 (1), 358-369, 2017
852017
Tacrolimus-loaded nanostructured lipid carriers for oral delivery–Optimization of production and characterization
S Khan, M Shaharyar, M Fazil, S Baboota, J Ali
European Journal of Pharmaceutics and Biopharmaceutics 108, 277-288, 2016
782016
Adaptation of quality by design-based development of isradipine nanostructured–lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate
T Alam, S Khan, B Gaba, MF Haider, S Baboota, J Ali
Journal of pharmaceutical sciences 107 (11), 2914-2926, 2018
612018
3D printing methods for pharmaceutical manufacturing: opportunity and challenges
MH Warsi, M Yusuf, M Al Robaian, M Khan, A Muheem, S Khan
Current pharmaceutical design 24 (42), 4949-4956, 2018
582018
Impact of neutropenia on delivering planned chemotherapy for solid tumours
S Khan, A Dhadda, D Fyfe, S Sundar
European journal of cancer care 17 (1), 19-25, 2008
562008
Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation
S Khan, S Baboota, J Ali, RS Narang, JK Narang
Drug development and industrial pharmacy 42 (2), 209-220, 2016
492016
Optimization of rivastigmine nanoemulsion for enhanced brain delivery: In-vivo and toxicity evaluation
MF Haider, S Khan, B Gaba, T Alam, S Baboota, J Ali, A Ali
Journal of molecular liquids 255, 384-396, 2018
462018
Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement
S Khan, M Shaharyar, M Fazil, MQ Hassan, S Baboota, J Ali
European Journal of Pharmaceutics and Biopharmaceutics 109, 149-157, 2016
442016
Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma
A Qidwai, S Khan, S Md, M Fazil, S Baboota, JK Narang, J Ali
Drug delivery 23 (4), 1476-1485, 2016
442016
γ-Irradiated chitosan based injectable hydrogels for controlled release of drug (Montelukast sodium)
S Hafeez, A Islam, N Gull, A Ali, SM Khan, S Zia, K Anwar, SU Khan, ...
International journal of biological macromolecules 114, 890-897, 2018
352018
Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress
B Nabi, S Rehman, M Fazil, S Khan, S Baboota, J Ali
Drug development and industrial pharmacy 46 (3), 471-483, 2020
312020
Role of P‐glycoprotein inhibitors in the bioavailability enhancement of solid dispersion of Darunavir
S Rehman, B Nabi, M Fazil, S Khan, NK Bari, R Singh, S Ahmad, V Kumar, ...
BioMed Research International 2017 (1), 8274927, 2017
312017
Sodium alginate blended membrane with polyurethane: Desalination performance and antimicrobial activity evaluation
SU Khan, M Sultan, A Islam, A Sabir, S Hafeez, I Bibi, MN Ahmed, ...
International Journal of Biological Macromolecules 182, 72-81, 2021
252021
Immunosuppressive drug therapy–biopharmaceutical challenges and remedies
S Khan, S Khan, S Baboota, J Ali
Expert opinion on drug delivery 12 (8), 1333-1349, 2015
252015
Ligand conjugation: An emerging platform for enhanced brain drug delivery
B Nabi, S Rehman, S Khan, S Baboota, J Ali
Brain Research Bulletin 142, 384-393, 2018
232018
Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus–targeting thrombogenesis
S Khan, S Khan, M Imran, KK Pillai, M Akhtar, AK Najmi
Expert opinion on therapeutic targets 17 (6), 627-639, 2013
222013
Relevant π-hole tetrel bonding interactions in ethyl 2-triazolyl-2-oxoacetate derivatives: Hirshfeld surface analysis and DFT calculations
MN Ahmed, KA Yasin, S Aziz, SU Khan, MN Tahir, DM Gil, A Frontera
CrystEngComm 22 (21), 3567-3578, 2020
202020
Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus
S Khan, S Khan, BP Panda, M Akhtar, AK Najmi
Expert Opinion on Therapeutic Targets 19 (12), 1607-1616, 2015
182015
系统目前无法执行此操作,请稍后再试。
文章 1–20